HuGE Literature Finder
Records
1
-
17
| Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study. BMC cancer 2021 Jul 21 (1): 872. Hajj Aline, Hachem Roula, Khoury Rita, Hallit Souheil, ElJEBBAWI Bashar, Nasr Fady, El Karak Fadi, Chahine Georges, Kattan Joseph, Rabbaa Khabbaz Lyd |
| Fear of pain moderates the relationship between self-reported fatigue and methionine allele of catechol-O-methyltransferase gene in patients with fibromyalgia. PloS one 2021 16 (4): e0250547. Ferrera David, Mercado Francisco, Peláez Irene, Martínez-Iñigo David, Fernandes-Magalhaes Roberto, Barjola Paloma, Écija Carmen, Díaz-Gil Gema, Gómez-Esquer Francis |
| Brain-derived neurotrophic factor polymorphism Val66Met protects against cancer-related fatigue. Translational psychiatry 2020 Aug 10 (1): 302. Feng Li Rebekah, Juneau Paul, Regan Jeniece M, Liwang Josephine, Alshawi Sarah, Wang Angela, Saligan Leorey |
| Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86). Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Jan . Dhani Neesha C, Hirte Hal W, Wang Lisa, Burnier Julia V, Jain Angela, Butler Marcus O, Welch Stephen, Fleming Gini F, Hurteau Jean, Matsuo Koji, Matei Daniela, Jimenez Waldo, Johnston Carolyn, Cristea Mihaela, Tonkin Katia, Ghatage Prafull, Lheureux Stephanie, Mehta Anjali, Quintos Judy, Tan Qian, Kamel-Reid Suzanne, Ludkovski Olga, Tsao Ming-Sound, Wright John J, Oza Amit |
| Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2018 Mar 117 44-49. Gerber David E, Socinski Mark A, Neal Joel W, Wakelee Heather A, Shirai Keisuke, Sequist Lecia V, Rosovsky Rachel P, Lilenbaum Rogerio C, Bastos Bruno R, Huang Chao, Johnson Melissa L, Hesketh Paul J, Subramaniam Deepa S, Dietrich Martin F, Chai Feng, Wang Yunxia, Kazakin Julia, Schwartz Brian, Schiller Joan H, Brahmer Julie R, Kelly Ronan |
| A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196. Oncotarget 2017 Sep 8 (41): 69651-69662. Leighl Natasha B, Tsao Ming-Sound, Liu Geoffrey, Tu Dongsheng, Ho Cheryl, Shepherd Frances A, Murray Nevin, Goffin John R, Nicholas Garth, Sakashita Shingo, Chen Zhuo, Kim Lucia, Powers Jean, Seymour Lesley, Goss Glenwood, Bradbury Penelope |
| A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors. Investigational new drugs 2016 Dec . Kyriakopoulos Christos E, Braden Amy M, Kolesar Jill M, Eickhoff Jens C, Bailey Howard H, Heideman Jennifer, Liu Glenn, Wisinski Kari |
| Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer. Expert review of clinical pharmacology 2015 Nov 1-11. Krajewska Jolanta, Olczyk Tomasz, Jarzab Barba |
| Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome. Journal of translational medicine 2015 13 (1): 264. Löbel Madlen, Mooslechner Agnes Anna, Bauer Sandra, Günther Sabrina, Letsch Anne, Hanitsch Leif G, Grabowski Patricia, Meisel Christian, Volk Hans-Dieter, Scheibenbogen Carm |
| The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Jun 24 (6): 1653-9. Yamamoto N, Murakami H, Nishina T, Hirashima T, Sugio K, Muro K, Takahashi T, Naito T, Yasui H, Akinaga S, Koh Y, Boku |
| Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-a treatment. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2013 May 38 (6): 985-95. Lotrich Francis E, Albusaysi Salwa, Ferrell Robert |
| Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jan 31 (2): 181-6. Choueiri Toni K, Vaishampayan Ulka, Rosenberg Jonathan E, Logan Theodore F, Harzstark Andrea L, Bukowski Ronald M, Rini Brian I, Srinivas Sandy, Stein Mark N, Adams Laurel M, Ottesen Lone H, Laubscher Kevin H, Sherman Laurie, McDermott David F, Haas Naomi B, Flaherty Keith T, Ross Robert, Eisenberg Peter, Meltzer Paul S, Merino Maria J, Bottaro Donald P, Linehan W Marston, Srinivasan Ramapras |
| Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors. Breast cancer research and treatment 2012 Jun 133 (2): 405-12. Fernández-de-las-Peñas César, Fernández-Lao Carolina, Cantarero-Villanueva Irene, Ambite-Quesada Silvia, Rivas-Martínez Inés, del Moral-Avila Rosario, Arroyo-Morales Manu |
| Influence of catechol-o-methyltransferase genotype (Val158Met) on endocrine, sympathetic nervous and mucosal immune systems in breast cancer survivors. Breast (Edinburgh, Scotland) 2012 Apr 21 (2): 199-203. Fernández-de-Las-Peñas César, Cantarero-Villanueva Irene, Fernández-Lao Carolina, Ambite-Quesada Silvia, Díaz-Rodríguez Lourdes, Rivas-Martínez Inés, del Moral-Avila Rosario, Arroyo-Morales Manu |
| Dopaminergic polymorphisms associated with time-on-task declines and fatigue in the Psychomotor Vigilance Test. PloS one 2012 7 (3): e33767. Lim Julian, Ebstein Richard, Tse Chun-Yu, Monakhov Mikhail, Lai Poh San, Dinges David F, Kwok Kenne |
| Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Feb 28 (4): 614-9. Adjei Alex A, Mandrekar Sumithra J, Dy Grace K, Molina Julian R, Adjei Araba A, Gandara David R, Ziegler Katie L Allen, Stella Philip J, Rowland Kendrith M, Schild Steven E, Zinner Ralph |
| The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia. Clinical and experimental rheumatology 0 27 (5 Suppl 56): S51-6. Cohen H, Neumann L, Glazer Y, Ebstein R P, Buskila |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: